In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC; Real‑world evidence showed Pluvicto achieved longer PFS when init ...

When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don't fight them - throw them in the cellular trash.

A research team led by the University of Waterloo is developing a novel tool to treat cancer by engineering hungry bacteria to literally eat tumors from the inside out.

The approval was based on the AMPLIFY trial, which evaluated acalabrutinib alongside venetoclax in adults with previously untreated CLL without del(17p) or TP53 mutation.

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

Blood tests are helpful for monitoring your overall health. But research suggests they can also give us clues about the ...

HHS states it was cleaning up "dated content." But advocates for people with autism say the warnings are still needed.

The Department of Health and Human Services quietly removed an advisory on its website warning users against deceptive ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. A new report found that colorectal cancer is now the ...

Jenna Scott remembers the joy of being pregnant with her first and only child. She also remembers the immense abdominal pain. During her pregnancy, she let her doctors know about the persistent ...